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Purpose: The meniscus is poorly vascularized and thus has limited 
healing capacity. Recent studies demonstrated potential application 
of cell-based therapy to incurable meniscal lesions. As a potential 
strategy for cell-based therapy, we have developed a novel scaffold-
free three-dimentional bioengineered tissue (3DBT) derived from 
synovium. Although scaffold-free, the 3DBT possesses self-supporting 
mechanical properties to withstand surgical handling. Moreover, 
the 3DBT is adhesive to cartilage matrix and have chondrogenic 
differentiating capacity (ICRS 2006). The purpose of this study was to 
test the feasibility of the 3DBT to repair avascular meniscal lesion. 
Methods and Materials: The synovial cells were isolated from the 
NBUVSFNJOJBUVSFQJHµTLOFFBOEDVMUVSFEVOUJMDPO¿VFOUDPOEJUJPO
The monolayer culture was then detached from the substratum by 
exerting shear stress and allowed active contraction of monolayer 
culture complex to develop a 3D-structure. A 4mm cylindrical defect 
was created at the avascular portion of the medial meniscus in 
skeletally matured miniature-pig. The defect was implanted by the 
3DBT (n=8) or was left empty (n=8). After 6 months, the repaired 
tissue and articular cartilage was morphologically evaluated. 
Results: The 3DBT-treated defects were securely repaired by 
¾CSPVTUJTTVFXJUIHPPEUJTTVFJOUFHSBUJPOUPUIFBEKBDFOUNFOJTDBM
tissue. In contrast, there were none, or only partial repair responses 
observed in the untreated defects. Notably, focal articular erosions 
as mirror changes were observed at both the femoral and tibial 
articular surfaces in 30% of untreated knees, while no mirror lesion 
was developed in the treated knee. 
Conclusions: The 3DBT could be feasible to promote incurable 
meniscal repair.
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Purpose: Meniscus loss increases knee degeneration, leading to 
additional surgeries or TKR. We determined if replacement of lost 
meniscus tissue with Collagen Meniscus Implants (CMI) decreased 
need for additional surgeries in multi-operated knees using a 
statistical “survivorship” analysis. 
Methods and Materials: Patients 18 to 60 years old who had 
undergone one to three partial medial meniscectomies with current 
meniscus symptoms were prospectively randomized (Level of 
Evidence I) to receive CMI or have additional partial meniscectomy 
(controls). Seventy-seven CMI were implanted, but 5 were removed 
within 6 months for technical reasons and were excluded from this 
analysis. The remaining 72 CMI were compared to 66 meniscectomy 
only controls over 4 years to determine survivorship. “Survivorship” 
XBTEF¾OFEBTOPUIBWJOHBOVOQMBOOFETVSHFSZPOUIFTUVEZLOFF
Results: Four CMI (6%) and 12 controls (18%) required reoperation 
through 4 years. Survivorship at one year was 89% for controls and 
97% for CMI, 87% and 95% at 2 years, 83% and 94% at 3 years, and 
BOEBUZFBSTSFTQFDUJWFMZ$.*QBUJFOUTIBETJHOJ¾DBOUMZ
IJHIFSTVSWJWPSTIJQUIBODPOUSPMT	Q
$PO¾EFODFJOUFSWBM	$*

analysis revealed that meniscectomy only controls were 3.8 times 
[CI 95%: 1.2 to 12.4] more likely to require repeat surgery than CMI 
patients who retained the implant. 
Conclusions: In patients retaining the implant, CMI decreased need 
for additional surgery in multi-operated knees. Additional CMI 
regenerated tissue decreased degenerative changes and reduced 
OFDFTTJUZ GPS BEEJUJPOBM TVSHFSJFT 5IFTF ¾OEJOHT TVQQPSU UIF
QPTJUJWFCFOF¾UTPG SFHFOFSBUJOH MPTUNFOJTDVT UJTTVF UPNJOJNJ[F
reoperations. 
